Literature DB >> 20441926

The synthesis and characterization of cellular membrane affinity chromatography columns for the study of human multidrug resistant proteins MRP1, MRP2 and human breast cancer resistant protein BCRP using membranes obtained from Spodoptera frugiperda (Sf9) insect cells.

Prateek A Bhatia1, Ruin Moaddel, Irving W Wainer.   

Abstract

CMAC (cellular membrane affinity chromatography columns) have been developed for the study of the human multidrug transporters MRP1, MRP2 and the breast cancer resistance protein (BCRP). The columns were constructed using the immobilized artificial membrane (IAM) stationary phase and cellular membrane fragments obtained from Spodoptera frugiperda (Sf9) cells that had been stably transfected with human Mrp1, Mrp2 or Bcrp cDNA, using a baculovirus expression system. The resulting CMAC(Sf9(MRP1)), CMAC(Sf9(MRP2)) and CMAC(Sf9(BCRP)) columns and a control column produced using membrane fragments from non-transfected Sf9 cells, CMAC(Sf9), were characterized using frontal affinity chromatography using [(3)H]-etoposide as the marker ligand and etoposide, benzbromarone and MK571 as the displacers on the CMAC(Sf9(MRP1)) column, etoposide and furosemide on the CMAC(Sf9(MRP2)) column and etoposide and fumitremorgin C on the CMAC(Sf9(BCPR)) column. The binding affinities (K(i) values) obtained from the chromatographic studies were consistent with the data obtained using non-chromatographic techniques and the results indicate that the immobilized MRP1, MRP2 and BCRP transporters retained their ability to selectively bind known ligands. (S)-verapamil displaced [(3)H]-etoposide on the CMAC(Sf9(MRP1)) column to a greater extent than (R)-verapamil and the relative IC(50) values of the enantiomers were calculated using the changes in the retention times of the marker. The observed enantioselectivity and calculated IC(50) values were consistent with previously reported data. The results indicated that the CMAC(Sf9(MRP1)), CMAC(Sf9(MRP2)) and CMAC(Sf9(BCRP)) columns can be used for the study of binding to the MRP1, MRP2 and BCRP transporters and that membranes from the Sf9 cell line can be used to prepare CMAC columns. This is the first example of the use of membranes from a non-mammalian cell line in an affinity chromatographic system.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20441926      PMCID: PMC2865475          DOI: 10.1016/j.talanta.2010.02.055

Source DB:  PubMed          Journal:  Talanta        ISSN: 0039-9140            Impact factor:   6.057


  48 in total

1.  The synthesis and initial characterization of an immobilized purinergic receptor (P2Y1) liquid chromatography stationary phase for online screening.

Authors:  Ruin Moaddel; Enrica Calleri; Gabriella Massolini; Chester R Frazier; Irving W Wainer
Journal:  Anal Biochem       Date:  2007-02-22       Impact factor: 3.365

2.  Interactions of mefloquine with ABC proteins, MRP1 (ABCC1) and MRP4 (ABCC4) that are present in human red cell membranes.

Authors:  Chung-Pu Wu; Antonios Klokouzas; Stephen B Hladky; Suresh V Ambudkar; Margery A Barrand
Journal:  Biochem Pharmacol       Date:  2005-08-15       Impact factor: 5.858

Review 3.  Anticancer multidrug resistance mediated by MRP1: recent advances in the discovery of reversal agents.

Authors:  Ahcène Boumendjel; Hélène Baubichon-Cortay; Doriane Trompier; Thomas Perrotton; Attilio Di Pietro
Journal:  Med Res Rev       Date:  2005-07       Impact factor: 12.944

4.  Multidrug resistance protein MRP1 protects against the toxicity of the major lipid peroxidation product 4-hydroxynonenal.

Authors:  J Renes; E E de Vries; G J Hooiveld; I Krikken; P L Jansen; M Müller
Journal:  Biochem J       Date:  2000-09-01       Impact factor: 3.857

5.  Characterization and application of a vinblastine-selected CACO-2 cell line for evaluation of p-glycoprotein.

Authors:  Dennis A Laska; Jack O Houchins; Susan E Pratt; Jeffery Horn; Xialong Xia; Brenda R Hanssen; Daniel C Williams; Anne H Dantzig; Terry Lindstrom
Journal:  In Vitro Cell Dev Biol Anim       Date:  2002 Jul-Aug       Impact factor: 2.416

Review 6.  Substrates and inhibitors of human multidrug resistance associated proteins and the implications in drug development.

Authors:  Shu-Feng Zhou; Lin-Lin Wang; Yuan Ming Di; Charlie Changli Xue; Wei Duan; Chun Guang Li; Yong Li
Journal:  Curr Med Chem       Date:  2008       Impact factor: 4.530

Review 7.  Multidrug resistance mediated by the breast cancer resistance protein BCRP (ABCG2).

Authors:  L Austin Doyle; Douglas D Ross
Journal:  Oncogene       Date:  2003-10-20       Impact factor: 9.867

8.  Pharmacophore modelling of stereoselective binding to the human organic cation transporter (hOCT1).

Authors:  R Moaddel; S Ravichandran; F Bighi; R Yamaguchi; I W Wainer
Journal:  Br J Pharmacol       Date:  2007-06-25       Impact factor: 8.739

9.  Identification of novel specific and general inhibitors of the three major human ATP-binding cassette transporters P-gp, BCRP and MRP2 among registered drugs.

Authors:  Pär Matsson; Jenny M Pedersen; Ulf Norinder; Christel A S Bergström; Per Artursson
Journal:  Pharm Res       Date:  2009-05-07       Impact factor: 4.200

10.  Identification of P-glycoprotein substrates using open tubular chromatography on an immobilized P-glycoprotein column: Comparison of chromatographic results with Caco-2 permeability.

Authors:  Ruin Moaddel; Rachid Hamid; Sharvil Patel; Peter L Bullock; Irving W Wainer
Journal:  Anal Chim Acta       Date:  2006-03-10       Impact factor: 6.558

View more
  6 in total

1.  The synthesis and characterization of a nuclear membrane affinity chromatography column for the study of human breast cancer resistant protein (BCRP) using nuclear membranes obtained from the LN-229 cells.

Authors:  K-L Habicht; C Frazier; N Singh; R Shimmo; I W Wainer; R Moaddel
Journal:  J Pharm Biomed Anal       Date:  2012-10-08       Impact factor: 3.935

Review 2.  Drug discovery from natural products - Old problems and novel solutions for the treatment of neurodegenerative diseases.

Authors:  Urmila Maitra; Cayman Stephen; Lukasz M Ciesla
Journal:  J Pharm Biomed Anal       Date:  2021-12-24       Impact factor: 3.935

3.  Characterization of a multiple endogenously expressed adenosine triphosphate-binding cassette transporters using nuclear and cellular membrane affinity chromatography columns.

Authors:  K-L Habicht; N S Singh; M A Khadeer; R Shimmo; I W Wainer; R Moaddel
Journal:  J Chromatogr A       Date:  2014-03-05       Impact factor: 4.759

Review 4.  Recent developments in protein-ligand affinity mass spectrometry.

Authors:  Niels Jonker; Jeroen Kool; Hubertus Irth; Wilfried M A Niessen
Journal:  Anal Bioanal Chem       Date:  2010-11-08       Impact factor: 4.142

5.  Secretory expression and purification of Bacillus licheniformis keratinase in insect cells.

Authors:  Miaorong Huang; Ruiai Chen; Guangcai Ren
Journal:  PLoS One       Date:  2017-08-23       Impact factor: 3.240

6.  R- Is Superior to S-Form of α-Lipoic Acid in Anti-Inflammatory and Antioxidant Effects in Laying Hens.

Authors:  Qingxiu Liu; Wenxiang Li; Shimeng Huang; Lihong Zhao; Jianyun Zhang; Cheng Ji; Qiugang Ma
Journal:  Antioxidants (Basel)       Date:  2022-08-05
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.